This announcement is a separate document:
未名医药:浙江天册(深圳)律师事务所关于山东未名生物医药股份有限公司2024年股票期权激励计划(草案)的法律意见书
Unnamed Medicine: Legal Opinion of Zhejiang Tianzu (Shenzhen) Law Firm on Shandong Weiming Biomedical Co., Ltd. 2024 Stock Option Incentive Plan (Draft)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.